您当前所在位置: 首页 > 学者

杨洁

  • 34浏览

  • 0点赞

  • 0收藏

  • 0分享

  • 75下载

  • 0评论

  • 引用

期刊论文

Temporal evolution of soluble Fas and Fas ligand in patients with orthotopic liver transplantation

杨洁Yuliang Wang abe* Yawu Liu c Ruifa Han d Jie Yang e Zhijun Zhu a Yanyan Zhang df Zhi Yao e Wei Gao a Zhongyang Shen a

Cytokine 41 (2008) 240-243,-0001,():

URL:

摘要/描述

Aim: The aim of this study was to analyze the expression levels of plasma soluble Fas (sFas) and soluble Fas ligand (sFasL) in patients with orthotopic liver transplantation (OLT) procedures routinely performed without venovenous bypass. Methods: The sFas and sFasL were analyzed in the blood of 20 consecutive patients who underwent transplantation. Blood amples were drawn from the radial artery at serial time points before, during, and after surgery. Plasma levels of sFas and sFasL were detected by Enzyme Linked-Immuno-Sorbent Assay. Plasma aspartate transaminase (AST) and alanine transaminase (ALT) were assayed by routine clinical chemistry esting. Results: Marked elevation of plasma AST and ALT were detected at the reperfusion and postoperation time points (P < 0.001), with a peak on the first postoperative day. The mean plasma concentration of sFas and sFasL remained unchanged from preoperative to anhepatic phase (T1 to T3) (P P 0.268). The sFas and sFasL concentrations were significantly higher at 15 and 60 min after reperfusion compared to the preoperative value (P 6 0.048). Postoperatively, sFas and sFasL concentration were decreased to preoperative levels on the first postoperative day (PP 0.127). Conclusion: The sFas and sFasL seem to be involved in reperfusion injury during OLT. he understanding of Fas may provide new insights into the mechanisms of ischemia/reperfusion injury during OLT.

【免责声明】以下全部内容由[杨洁]上传于[2011年06月20日 15时31分33秒],版权归原创者所有。本文仅代表作者本人观点,与本网站无关。本网站对文中陈述、观点判断保持中立,不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考,并请自行承担全部责任。

我要评论

全部评论 0

本学者其他成果

    同领域成果